Lessons from Multiple Infections Such as Lymphoma Complicated with Pneumocystis Infection: A Case Report
DOI: https://doi.org/10.2147/idr.s461607
2024-04-23
Infection and Drug Resistance
Abstract:Huaichong Wang, 1 Yuying Lang, 1 Xinjun Cai, 1 Liujie Gao, 2 Shengya Yang, 3 Jie Jin 1 1 Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang Province, People's Republic of China; 2 Department of Oncology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang Province, People's Republic of China; 3 Tuberculosis Diagnosis and Treatment Center, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang Province, People's Republic of China Correspondence: Jie Jin, Department of Pharmacy, Hangzhou Red Cross Hospital, East Huancheng Road No. 208, Hangzhou, Zhejiang Province, People's Republic of China, Email Background: Lymphoma is complicated by intricate infections, notably Pneumocystis jirovecii pneumonia (PJP), marked by rapid progression, respiratory failure, and high mortality. Rapid diagnosis of PJP and effective administration of the first-line treatment trimethoprim-sulfamethoxazole (TMP-SMX) are important. For patients intolerant to TMP-SMX, selecting appropriate alternatives is challenging, necessitating careful decisions to optimize diagnosis and treatment. We present a lymphoma case complicated by PJP, illustrating medication adjustment until a positive response was observed. Case Description: A 41-year-old male patient with lymphoma presented with a week-long history of fever, fatigue, cough, sputum, chest tightness, and exertional dyspnea, unresponsive to treatment. Routine laboratory examinations revealed no pathogenic bacteria. PJ and Mycobacterium tuberculosis (MTB) were detected in bronchoalveolar lavage fluid (BALF) using metagenomic next-generation sequencing (mNGS). On Day 1 of admission, meropenem, TMP-SMX, and rifampicin+isoniazid+levofloxacin were administered. However, the patient developed drug-induced hepatotoxicity and gastrointestinal adverse reactions after six days of treatment. After a multidisciplinary team discussion, anti-tuberculosis therapy was stopped because of insufficient evidence of tuberculosis infection. A reduced dose of TMP-SMX with micafungin was used for PJP; however, symptoms persisted and repeated computed tomography showed extensive deterioration of bilateral pulmonary plaques. The PJP regimen was modified to include a combination of TMP-SMX and caspofungin. Due to the high fever and elevated infection indices, the patient was treated with teicoplanin to enhance the anti-infection effects. By Day 13, the patient's temperature had normalized, and infection control was achieved by Day 30. CT revealed that the infection in both lung lobes fully resolved. Subsequently, lymphoma treatment commenced. Conclusion: BALF-NGS facilitates early and rapid diagnosis of PJP. mNGS reads of MTB bacillus < 5 may indicate a bacterial carrier state, warranting other detection techniques to support it. There is insufficient evidence for using TMP-SMX with micafungin to treat PJP; however, TMP-SMX combined with caspofungin is suitable. Keywords: bronchoalveolar lavage fluid, metagenomic next-generation sequencing, Pneumocystis jirovecii pneumonia, Mycobacterium tuberculosis , trimethoprim-sulfamethoxazole Infectious diseases have a rapid onset and progression, and the causative agents in severe cases are complex, difficult to diagnose and treat, and can endanger lives. Pneumocystis jirovecii pneumonia (PJP) is caused by Pneumocystis jirovecii (PJ) infection, a life-threatening pulmonary infectious disease. When host immune function is low, especially when cellular immunity is impaired, PJ infection easily develops. High-risk populations include patients with human immunodeficiency virus (HIV) infection, hematopoietic malignancies (including leukemia, lymphoma, and multiple myeloma), solid tumors, inflammatory diseases, long-term glucocorticoid use, immunosuppression, and those who have undergone organ transplantation. 1,2 The accurate identification of PJ is critical, 3 microscopic examination remains the gold standard for diagnosing PJP. However, immunofluorescence staining for PJ is not widely used in hospitals, and its diagnostic sensitivity is low. Newly developed technologies for molecular testing complement clinical diagnoses. Metagenomic next-generation sequencing (mNGS) detection technology does not rely on traditional microbial culture and directly conducts high-throughput sequencing of nucleic acids in clinical samples, promptly and objectively detecting various pathogenic microorganisms, significantly improving pathogen detection sensitivity, and has advantages in identifying the rare manifestations of common pathogen infections and diagnosing rare pathogen infections. 4 Trimethoprim-sulfamethoxazole (TMP-SMX) is the first-line eff -Abstract Truncated-
pharmacology & pharmacy,infectious diseases